These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Genentech makes splash on Wall Street. Dickson D Nature; 1980 Oct; 287(5784):669-70. PubMed ID: 6933314 [No Abstract] [Full Text] [Related]
3. Cloning gold rush turns basic biology into big business. Wade N Science; 1980 May; 208(4445):688-92. PubMed ID: 6929110 [No Abstract] [Full Text] [Related]
4. Swiss company takes a 60 per cent stake in Genentech. Gershon D Nature; 1990 Feb; 343(6258):495. PubMed ID: 2300193 [No Abstract] [Full Text] [Related]
5. From lab bench to Wall Street. Bartfai T FASEB J; 2006 Aug; 20(10):1578-80. PubMed ID: 16873880 [No Abstract] [Full Text] [Related]
6. The microbiological production of pharmaceuticals. Aharonowitz Y; Cohen G Sci Am; 1981 Sep; 245(3):140-52. PubMed ID: 6116278 [No Abstract] [Full Text] [Related]
7. A revolution in biology. Abelson J Science; 1980 Sep; 209(4463):1319-21. PubMed ID: 6251541 [No Abstract] [Full Text] [Related]
8. Erlotinib: CP 358774, NSC 718781, OSI 774, R 1415. Adis International Ltd Drugs R D; 2003; 4(4):243-8. PubMed ID: 12848590 [TBL] [Abstract][Full Text] [Related]
9. Selling growth drug for children: the legal and ethical questions. Kolata G N Y Times Web; 1994 Aug; ():A1, A13. PubMed ID: 11647981 [No Abstract] [Full Text] [Related]
16. Company tried to bar report that H.I.V. vaccine failed. Hilts PJ N Y Times Web; 2000 Nov; ():A24. PubMed ID: 12159838 [No Abstract] [Full Text] [Related]
17. Genentech caps cost of cancer drug for some patients. Pollack A N Y Times Web; 2006 Oct; ():C2. PubMed ID: 17061339 [No Abstract] [Full Text] [Related]
18. Cochrane at crossroads over drug company sponsorship. Moynihan R BMJ; 2003 Oct; 327(7420):924-6. PubMed ID: 14563759 [TBL] [Abstract][Full Text] [Related]